On February 11, the Michigan Society of Addiction Medicine (MISAM) submitted comments on a proposed policy, 2067-AUD/OUD, released by the Michigan Department of Health and Human Services (MDHHS) which would expand Medicaid reimbursement options for clinicians in Michigan who treat addiction outside of the state’s separate Medicaid behavioral health system

New guidelines endorsed by more than 30 leading health groups, including the American Medical Association, call for focus on addiction treatment and prevention, avoid diversion of funds to close budget gaps.

Treatment professional and addiction-related advocacy groups urge Congress to eliminate the X-waiver, which creates an unnecessary barrier to prescribing buprenorphine, and to prioritize education for addiction treatment.

The Minnesota Society of Addiction Medicine (MNSAM) submitted a letter of support for SF61/HF19, companion bills which would remove the “buy and bill” requirement from all practitioner administered medications for substance use disorders (SUD).

ASAM released its 2020 Advocacy Year in Review, which provides an overview of some of the new policies and resources that ASAM and its State Chapters helped advance in 2020, by working closely with federal and state policy-makers and other key stakeholders.

The American Society of Addiction Medicine (ASAM), sent a letter to provide comments on the Interim Final Rule on the Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment (the “Interim Final Rule”).

Today the American Society of Addiction Medicine (ASAM) commended Congress for yesterday’s passage of several important addiction-related provisions in its bipartisan, end-of-year spending package that will increase Americans’ access to addiction treatment.

The Kentucky Society of Addiction Medicine (KYSAM) sent a letter to the Kentucky Board of Nursing, expressing KYSAM’s strong support for the Advanced Practice Registered Nurse (APRN) Council’s recommended amendments to Kentucky’s professional standards for Kentucky APRNs who prescribe buprenorphine for the treatment of opioid use disorder (OUD). With the opioid addiction and overdose epidemic significantly impacting the country and Kentucky, KYSAM greatly appreciated the APRN Council’s efforts to increase access to evidence-based OUD treatment and encouraged the Kentucky Board of Nursing to adopt the APRN Council’s recommendations.